LGND Stockholders Equity
Ligand Pharmaceuticals Inc · Stockholders Equity
LGND Stockholders Equity
Latest reported$1.02Bperiod ending
LGND FY Shareholders Equity ($26.30M → $1.02B)
Annual shareholders equity
High-resolution chart · PNG
LGND stockholders equity history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stockholders Equity (USD) |
|---|---|
| 1,017,212,000 | |
| 830,439,000 | |
| 700,913,000 | |
| 597,485,000 | |
| 821,159,000 | |
| 709,525,000 | |
| 767,232,000 | |
| 560,914,000 | |
| 418,647,000 | |
| 370,853,000 | |
| 304,391,000 | |
| 26,318,000 | |
| 49,613,000 | |
| 26,485,000 | |
| 8,646,000 | |
| -6,991,000 | |
| 3,744,000 | |
| -10,365,000 | |
| 29,115,000 | |
| 27,352,000 | |
| -110,419,000 | |
| -75,317,000 | |
| 70,728,000 | |
| 74,015,000 | |
| -57,875,000 | |
| -55,125,000 | |
| -25,600,000 | |
| -11,400,000 | |
| 34,300,000 | |
| 34,500,000 | |
| 28,100,000 | |
| 26,300,000 |